Emtricitabine Not Yet Recruiting Phase 4 Trials for Fibrosis / Hepatitis B Chronic Infection Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02327689Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients
NCT02327663Emtricitabine for Naive Chinese Chronic Hepatitis B Patients